Tumor Ablation Therapy Devices Growth Trajectory: Key Forecasts and Strategic Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Tumor Ablation Therapy Devices Market In 2029?
Recently, the market size for tumor ablation therapy devices has experienced significant growth. It is projected to increase from $0.72 billion in 2024 to $0.82 billion in 2025, maintaining a compound annual growth rate (CAGR) of 14.2%. The impressive growth rate in the historical period can be tied to factors such as the prevalence of cancer, technological progress, an ageing population, and the rise in minimally invasive procedures.
In the upcoming years, the market size of tumor ablation therapy devices is predicted to witness a swift expansion. The market is expected to balloon to an impressive amount of $1.42 billion in 2029, presenting a compound annual growth rate (CAGR) of 14.6%. The expected increase during the forecast era is due to factors such as personalized medicine, combination therapies, artificial intelligence and image-guided ablation, telemedicine coupled with remote consultations, and training plus education. The key trends during the projection period encompasses the progression in ablation technologies, imaging guidance, robotic aid and navigation assistance, the integration of immuno-oncology, and percutaneous along with image-guided ablation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
Which Factors and External Forces Are Driving Demand in the Tumor Ablation Therapy Devices Market?
The growing incidence of cancer is a significant force propelling the expansion of the tumor ablation therapy devices market. Being the second major cause of global fatalities, cancer is responsible for approximately 1 in 6 deaths across the globe. Tumor ablation, a minimally invasive procedure, is extensively employed in addressing lung, liver, kidney, and bone tumors. For example, projections from the American Cancer Society Inc., a non-profit health organization in the US, suggest that the number of new cancer cases diagnosed in the US in 2023 will reach 1,958,310, showing an increase from the more than 1,918,030 new cases recorded in 2022. Tumor ablation therapy is an effective alternative for patients whom chemotherapy or radiotherapy was unsuccessful, thus fostering the growth of the tumor ablation therapy devices market.
Which Segments in the Tumor Ablation Therapy Devices Offer the Most Growth?
The tumor ablation therapy devicesmarket covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3351&type=smp
What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Tumor Ablation Therapy Devices Market?# Market?
North America was the largest region in the tumor ablation therapy devices market in 2024. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Cutting-Edge Market Trends Are Expected to Drive theTumor Ablation Therapy Devices Market’s Growth?
Key players in tumor ablation therapy devices are concentrating on technological innovations to reduce procedure length, enhance safety, minimize radiation exposure, accelerate learning, and improve results. J&J Medicals has introduced a microwave ablation system named NEUWAVE. This is the first minimally invasive device that implant electrodes into the cancer cells which increases the surrounding temperature, leading to the destruction of cancer cells. Subsequently, in April 2023, Compal Electronics, an electronic manufacturer based in Taiwan, unveiled AblatePal, a novel radiofrequency ablation (RFA) system. This detailed system is purposed to carry out percutaneous, intraoperative coagulation and eliminate soft tissue, which includes either partial or total treatment of non-resectable liver lesions. It functions by utilizing the thermal energy generated by electrical resistance while the current is passing through the tissue, ultimately leading to the removal of the targeted tissue. This system is used in therapeutic medical devices and is designed to treat a variety of medical conditions, primarily cancer.
View the full report here:
What Are the Key Elements That Define the Tumor Ablation Therapy Devices Market?
Tumor ablation therapy devices are minimally invasive devices used in the treatment of tumors, commonly of kidney, liver, and lung. These devices work by employing various techniques to destroy cancerous cells while preserving surrounding healthy tissue.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3351
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model